MedTrace Logo

EEG Theta-Beta Ratio Neurofeedback-training

NCT02763618 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-09-12

No results posted yet for this study

Summary

This study will investigate the effects of an EEG theta/beta ratio Neurofeedback training using a case series multiple baseline design. Twelve participants will be assigned to one of three different groups that have a different time of intervention onset, or include placebo sessions only. The investigators will examine whether the theta/beta ratio Neurofeedback training will reduce resting state theta/beta ratio. As a pilot-exploration for future studies, also performance on a cognitive interference task will be monitored to see if any improvement after NFT on cognitive performance might be a viable subject for future studies. All participants (healthy, but selected for above-median theta/beta ratio in previous studies in this lab) will start with three resting state EEG baseline sessions, the first participant group then continues with 14 theta/beta ratio Neurofeedback sessions, the second group continues with six extra baseline EEG measurements, followed by eight Neurofeedback training sessions while the third group will continue with 14 placebo training sessions only. EEG resting state theta/beta ratio and interference performance will be measured during every session.

Conditions

  • Elevated EEG Theta/Beta Ratio

Interventions

OTHER

Neurofeedback

Neurofeedback theta/beta ratio training. See 'Neurofeedback theta/beta ratio training' in detailed study description.

OTHER

Placebo Neurofeedback training

The placebo training will be a previously recorded Neurofeedback session of a participant in group A

Sponsors & Collaborators

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Peter Putman, PhD · Leiden University, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
23 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02763618 on ClinicalTrials.gov